Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Diagnosis and/or prognosis of HER2-dependent cancer using one or more miRNA as a biomarker

Diagnosis and/or prognosis of HER2-dependent cancer using one or more miRNA as a biomarker

US Patent 11814685 · Granted Nov 14, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of HER-2 dependent cancer using an agent that modulates the activity o2022
Treatment of HER-2 dependent cancer using an agent that modulates the activity o2022
Treatment of HER-2 dependent cancer using an agent that modulates the activity o2022
Zuclopenthixol hydrochloride derivatives and Ebselen derivatives as ErbB2 inhibi2020
Zuclopenthixol hydrochloride derivatives and Ebselen derivatives as ErbB2 inhibi2020
CD147 as receptor for pilus-mediated adhesion of Meningococci to vascular endoth2018
Polypeptides and nucleic acids for treating ErbB2-dependent cancers2015